CQS (US)’s Globus Medical GMED Stock Holding History

CQS (US)’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-105,000	Closed	-$6.18M	–	128
2019 Q4	$6.18M	Buy	+105,000	New	+$5.7M	0.29%	81

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

CQS (US)'s GMED Position: Q2 2022 in Review

CQS (US) sold out of Globus Medical (GMED) in Q2 2022, closing a stake of 139,138 shares — an estimated $10.3M sold.

CQS (US) first reported a position in GMED in Q4 2019 and held it in 2 quarters. The position peaked at $10.3M in Q1 2022. 364 funds tracked by Wall St. Rank hold GMED as of Q2 2022.

CQS (US) reported no remaining Globus Medical position as of Q2 2022 after selling out during the quarter.
CQS (US) sold 139,138 Globus Medical shares in Q2 2022, an estimated $10.3M.
CQS (US) first reported a position in Globus Medical in Q4 2019 and held it in 2 quarters.
CQS (US)'s Globus Medical position peaked at $10.3M in Q1 2022.
364 funds tracked by Wall St. Rank held Globus Medical as of Q2 2022.

Based on CQS (US)'s 13F filing for Q2 2022, filed 12 Aug 2022.